减重手术的成本-效用分析
该研究基于英格兰视角构建状态转移马尔可夫模型,比较减重手术(胃旁路术、袖状胃切除术和可调节胃束带术)与非手术常规治疗在病态肥胖患者中的成本与结局。结果显示减重手术终生可节省医疗成本并增加生命年和质量调整生命年,且延迟手术会降低获益。
要点
- 减重手术可能降低肥胖相关心血管疾病和糖尿病的终生风险。
核心结论
- 在英格兰接受治疗的患者终生范围内,当前使用的减重手术方法具有成本节省效应。
研究设计与样本
- 研究构建状态转移马尔可夫模型,比较减重手术(包括胃旁路术、袖状胃切除术和可调节胃束带术)与非手术常规治疗在病态肥胖患者中的成本和结局。
- 手术效果和并发症参数来源于英国国家减重手术登记处、斯堪的纳维亚肥胖登记处和瑞典肥胖受试者研究,成本和效用数据来源于英国来源。
主要发现
- 减重手术有可能降低肥胖相关心血管疾病和糖尿病的终生风险。
临床怎么用
- 对于病态肥胖患者,减重手术在当前英格兰医疗背景下具有终生成本节省效应,可作为决策参考。
- 延迟手术可能降低QALY获益和成本节省幅度,提示及时评估手术时机的重要性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of the study was to evaluate the cost-utility of bariatric surgery in England. METHODS: A state-transition Markov model was developed to compare the costs and outcomes of two treatment approaches for patients with morbid obesity: bariatric surgery, including gastric bypass, sleeve gastrectomy and adjustable gastric banding; and non-surgical usual care. Parameters of the effectiveness of surgery and complications were informed by data from the UK National Bariatric Surgery Registry, the Scandinavian Obesity Registry and the Swedish Obese Subjects study. Costs and utilities were informed by UK sources. RESULTS: Bariatric surgery was associated with reduced mean costs to the health service by €2742 (£1944), and gain of 0·8 life-years and 4·0 quality-adjusted life-years (QALYs) over a lifetime compared with usual care. Bariatric surgery also had the potential to reduce the lifetime risks of obesity-related cardiovascular diseases and diabetes. Delaying surgery for up to 3 years resulted in a reduction of 0·7 QALYs and a minor decrease of €2058 (£1459) in associated healthcare costs. CONCLUSION: Currently used surgical methods were found to be cost saving over the lifetime of individuals treated in England.
引用
- Borisenko O, Lukyanov V, Ahmed AR, et al. Cost-utility analysis of bariatric surgery. Br J Surg. 2018. PMID: 29667178. doi:10.1002/bjs.10857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。